GR1002257B - Ophthalmic lens with anti-toxin agent. - Google Patents

Ophthalmic lens with anti-toxin agent.

Info

Publication number
GR1002257B
GR1002257B GR940100111A GR940100111A GR1002257B GR 1002257 B GR1002257 B GR 1002257B GR 940100111 A GR940100111 A GR 940100111A GR 940100111 A GR940100111 A GR 940100111A GR 1002257 B GR1002257 B GR 1002257B
Authority
GR
Greece
Prior art keywords
lens
cornea
eye
ester
ophthalmic lens
Prior art date
Application number
GR940100111A
Other languages
English (en)
Inventor
Clyde Schultz
Douglas Vanderlaan
Susan Brown-Skrobot
Original Assignee
Johnson & Johnson Vision Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Vision Prod filed Critical Johnson & Johnson Vision Prod
Publication of GR1002257B publication Critical patent/GR1002257B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
    • G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
    • G02B1/041—Lenses
    • G02B1/043—Contact lenses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/22—Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea
GR940100111A 1993-03-02 1994-03-01 Ophthalmic lens with anti-toxin agent. GR1002257B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/025,018 US5472703A (en) 1993-03-02 1993-03-02 Ophthalmic lens with anti-toxin agent

Publications (1)

Publication Number Publication Date
GR1002257B true GR1002257B (en) 1996-04-23

Family

ID=21823602

Family Applications (1)

Application Number Title Priority Date Filing Date
GR940100111A GR1002257B (en) 1993-03-02 1994-03-01 Ophthalmic lens with anti-toxin agent.

Country Status (25)

Country Link
US (1) US5472703A (el)
EP (1) EP0613694B1 (el)
JP (1) JP3390999B2 (el)
KR (1) KR940021079A (el)
CN (1) CN1099605C (el)
AT (1) ATE171077T1 (el)
AU (1) AU675101B2 (el)
BR (1) BR9400787A (el)
CA (1) CA2116834A1 (el)
CZ (1) CZ46194A3 (el)
DE (1) DE69413271T2 (el)
ES (1) ES2122163T3 (el)
FI (1) FI940976A (el)
GR (1) GR1002257B (el)
GT (1) GT199400014A (el)
HU (1) HU214060B (el)
IL (1) IL108820A (el)
NO (1) NO940707L (el)
NZ (1) NZ260004A (el)
PH (1) PH31000A (el)
RU (1) RU94007090A (el)
SG (1) SG63541A1 (el)
TW (1) TW289094B (el)
UY (1) UY23735A1 (el)
ZA (1) ZA941430B (el)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0733918B1 (en) * 1995-03-24 2003-07-30 Ocular Research of Boston, Inc. Hydrogel lens pre-coated with lipid layer
US5554187A (en) * 1995-08-18 1996-09-10 Rizzo, Iii; Joseph Medication dispensing intra-ocular lens system
CA2198972A1 (en) * 1996-03-05 1997-09-05 Clyde L. Schultz Contact lens containing a leachable absorbed antibody
US6592814B2 (en) 1998-10-02 2003-07-15 Johnson & Johnson Vision Care, Inc. Biomedical devices with antimicrobial coatings
US20070104798A1 (en) 1999-10-04 2007-05-10 S.K. Pharmaceuticals, Inc. Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide
FR2804868B1 (fr) * 2000-02-15 2003-03-07 Oreal Utilisation de composes permettant de modifier les proprietes physio-chimiques de la peau et/ou des muqueuses en tant qu'agents empechant ou diminuant l'adhesion des micro-organismes sur ces dernieres
FR2804865B1 (fr) * 2000-02-15 2003-11-28 Oreal Utilisation des corps gras particuliers permettant de modifier les proprietes physio-chimiques de la peau et/ou des muqueuses en tant qu'agents empechant ou diminuant l'adhesion des micro-organismes sur ces dernieres
MXPA03003542A (es) * 2000-10-24 2004-08-12 Bausch & Lomb Prevencion de la union bacterial a biomateriales mediante polisacaridos cationicos.
US7402318B2 (en) 2001-11-14 2008-07-22 Novartis Ag Medical devices having antimicrobial coatings thereon
US20030203032A1 (en) * 2002-04-25 2003-10-30 Schultz Clyde L. Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease
WO2003090662A2 (en) * 2002-04-25 2003-11-06 Rapidheal, Inc. Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease
US7282214B2 (en) * 2002-12-19 2007-10-16 Johnson & Johnson Vision Care, Inc. Biomedical devices with antimicrobial coatings
US9216106B2 (en) 2003-04-09 2015-12-22 Directcontact Llc Device and method for the delivery of drugs for the treatment of posterior segment disease
US20050074497A1 (en) * 2003-04-09 2005-04-07 Schultz Clyde L. Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
US20050255144A1 (en) * 2003-04-09 2005-11-17 Directcontact Llc Methods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases
US8541413B2 (en) * 2004-10-01 2013-09-24 Ramscor, Inc. Sustained release eye drop formulations
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
US20080102095A1 (en) * 2006-10-31 2008-05-01 Kent Young Acidic processes to prepare antimicrobial contact lenses
US20100120013A1 (en) * 2008-11-07 2010-05-13 Mb Research Laboratories, Inc. Procedure for long term corneal culture
US10383839B2 (en) 2011-06-30 2019-08-20 Johnson & Johnson Vision Care, Inc. Esters for treatment of ocular inflammatory conditions
US8974055B2 (en) 2013-03-15 2015-03-10 Johnson & Johnson Vision Care, Inc. Method and apparatus for encapsulating a rigid insert in a contact lens for correcting vision in astigmatic patients
US10816823B2 (en) 2015-05-04 2020-10-27 École Polytechnique Fédérale de Lausanne Ophthalmic contact lens with compressible affinity matrix
CN105410365B (zh) * 2015-12-17 2019-06-11 浙江大学 一种可替代抗生素的饲料添加剂及其应用
KR20210093609A (ko) 2020-01-20 2021-07-28 이원계 승용차의 창을 통해 내부로 유입되는 공기배출시스템
KR20220152722A (ko) 2021-05-10 2022-11-17 이원계 주행 중 승용차의 측면창을 통해 내부로 유입되는 공기배출시스템

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485029A (en) * 1984-03-19 1984-11-27 Minnesota Mining And Manufacturing Company Disinfecting method and compositions
CA1295941C (en) * 1985-08-16 1992-02-18 Rajan Bawa Sustained-release formulation comprising a hydrophobic polymer system
US4931279A (en) * 1985-08-16 1990-06-05 Bausch & Lomb Incorporated Sustained release formulation containing an ion-exchange resin
CA1302280C (en) * 1986-04-21 1992-06-02 Jon Joseph Kabara Topical antimicrobial pharmaceutical compositions and methods
US5208257A (en) * 1986-04-21 1993-05-04 Kabara Jon J Topical antimicrobial pharmaceutical compositions and methods
JPH01206312A (ja) * 1988-02-15 1989-08-18 Kao Corp コンタクトレンズ洗浄剤
US4921279A (en) * 1988-08-18 1990-05-01 Ncr Corporation MICR printing technique and apparatus to minimize rejects with correction stickers
JP3043362B2 (ja) * 1989-04-27 2000-05-22 マクニール―ピーピーシー・インコーポレーテツド タンポンへの添加剤

Also Published As

Publication number Publication date
HUT67519A (en) 1995-04-28
IL108820A0 (en) 1994-06-24
IL108820A (en) 1997-02-18
DE69413271T2 (de) 1999-04-08
NO940707L (no) 1994-09-05
CZ46194A3 (en) 1994-10-19
CN1099605C (zh) 2003-01-22
ES2122163T3 (es) 1998-12-16
CA2116834A1 (en) 1994-09-03
BR9400787A (pt) 1994-11-22
NZ260004A (en) 1995-12-21
ZA941430B (en) 1995-09-01
EP0613694A1 (en) 1994-09-07
US5472703A (en) 1995-12-05
NO940707D0 (no) 1994-03-01
GT199400014A (es) 1995-08-23
PH31000A (en) 1997-12-23
CN1101722A (zh) 1995-04-19
FI940976A0 (fi) 1994-03-01
UY23735A1 (es) 1994-06-16
JPH06343686A (ja) 1994-12-20
TW289094B (el) 1996-10-21
KR940021079A (ko) 1994-10-17
HU214060B (en) 1997-12-29
FI940976A (fi) 1994-09-03
DE69413271D1 (de) 1998-10-22
ATE171077T1 (de) 1998-10-15
AU675101B2 (en) 1997-01-23
SG63541A1 (en) 1999-03-30
AU5649394A (en) 1994-09-08
JP3390999B2 (ja) 2003-03-31
EP0613694B1 (en) 1998-09-16
HU9400618D0 (en) 1994-05-30
RU94007090A (ru) 1996-08-20

Similar Documents

Publication Publication Date Title
PH31000A (en) Ophthalmic lens with anti-toxin agent.
US5428412B1 (en) Method for treating myopia with an aspheric corneal contact lens
DE69002386T2 (de) Optische Komponente, beispielsweise intraokulares Implantat oder Kontaktlinse zur Sehkorrektur eines Individuums.
AU1387088A (en) Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocularpressure
GR3033776T3 (en) Thin intraocular lens.
EP0766970A3 (en) Method and composition for disinfecting contact lenses
DE69325000T2 (de) Künstliche Augenlinse mit verminderter Randblendung
WO1997028827A1 (fr) Composition ophtalmique possedant une viscosite adaptee
IT1277707B1 (it) Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare
ES2172515T3 (es) Combinacion de gafas difractivas/refractivas y lentes intraoculares para la degeneracion macular relacionada con la edad.
AU8170891A (en) Composition for eye drops
AU1311492A (en) Progressive ophthalmic lens
EP0562445A3 (en) Ophthalmic gel
EP0420598A3 (en) Contact lens based on a hydrophilic gel
NO171885C (no) Oftalmiske komfortdraape-opploesninger for intraokular anvendelse ved hydrogelkontaktlinser
AU8801291A (en) Device for ophthalmological use consisting of a polymeric substrate containing fluorine-containing groups at the surface, and preparation
GB2016736A (en) Contact lens having one or more lugs
JO1317B1 (en) Eye treatment
ES2076065A2 (es) Lente intraocular de correccion de alta miopia.